Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Change in Accured Expenses: 2013-2024

Historic Change in Accured Expenses for Astria Therapeutics (ATXS) over the last 12 years, with Dec 2024 value amounting to $3.7 million.

  • Astria Therapeutics' Change in Accured Expenses fell 36.43% to $82,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$205,000, marking a year-over-year decrease of 151.77%. This contributed to the annual value of $3.7 million for FY2024, which is 84.29% up from last year.
  • As of FY2024, Astria Therapeutics' Change in Accured Expenses stood at $3.7 million, which was up 84.29% from $2.0 million recorded in FY2023.
  • Over the past 5 years, Astria Therapeutics' Change in Accured Expenses peaked at $4.4 million during FY2022, and registered a low of -$1.3 million during FY2021.
  • Moreover, its 3-year median value for Change in Accured Expenses was $3.7 million (2024), whereas its average is $3.4 million.
  • Per our database at Business Quant, Astria Therapeutics' Change in Accured Expenses soared by 874.15% in 2020 and then crashed by 182.92% in 2021.
  • Astria Therapeutics' Change in Accured Expenses (Yearly) stood at $1.6 million in 2020, then slumped by 182.92% to -$1.3 million in 2021, then spiked by 434.88% to $4.4 million in 2022, then plummeted by 54.21% to $2.0 million in 2023, then soared by 84.29% to $3.7 million in 2024.